These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 35275912)
21. Kdo hydrolase is required for Francisella tularensis virulence and evasion of TLR2-mediated innate immunity. Okan NA; Chalabaev S; Kim TH; Fink A; Ross RA; Kasper DL mBio; 2013 Feb; 4(1):e00638-12. PubMed ID: 23404403 [TBL] [Abstract][Full Text] [Related]
22. Immunologic consequences of Francisella tularensis live vaccine strain infection: role of the innate immune response in infection and immunity. Cole LE; Elkins KL; Michalek SM; Qureshi N; Eaton LJ; Rallabhandi P; Cuesta N; Vogel SN J Immunol; 2006 Jun; 176(11):6888-99. PubMed ID: 16709849 [TBL] [Abstract][Full Text] [Related]
23. Cellular and humoral immunity are synergistic in protection against types A and B Francisella tularensis. Sebastian S; Pinkham JT; Lynch JG; Ross RA; Reinap B; Blalock LT; Conlan JW; Kasper DL Vaccine; 2009 Jan; 27(4):597-605. PubMed ID: 19022323 [TBL] [Abstract][Full Text] [Related]
24. Tularemia in BALB/c and C57BL/6 mice vaccinated with Francisella tularensis LVS and challenged intradermally, or by aerosol with virulent isolates of the pathogen: protection varies depending on pathogen virulence, route of exposure, and host genetic background. Chen W; Shen H; Webb A; KuoLee R; Conlan JW Vaccine; 2003 Sep; 21(25-26):3690-700. PubMed ID: 12922099 [TBL] [Abstract][Full Text] [Related]
25. Construction and characterization of an attenuated purine auxotroph in a Francisella tularensis live vaccine strain. Pechous R; Celli J; Penoske R; Hayes SF; Frank DW; Zahrt TC Infect Immun; 2006 Aug; 74(8):4452-61. PubMed ID: 16861631 [TBL] [Abstract][Full Text] [Related]
26. Francisella tularensis Schu S4 lipopolysaccharide core sugar and O-antigen mutants are attenuated in a mouse model of tularemia. Rasmussen JA; Post DM; Gibson BW; Lindemann SR; Apicella MA; Meyerholz DK; Jones BD Infect Immun; 2014 Apr; 82(4):1523-39. PubMed ID: 24452684 [TBL] [Abstract][Full Text] [Related]
28. Aim2 and Nlrp3 Are Dispensable for Vaccine-Induced Immunity against Francisella tularensis Live Vaccine Strain. Alqahtani M; Ma Z; Fantone K; Malik M; Bakshi CS Infect Immun; 2021 Jun; 89(7):e0013421. PubMed ID: 33875472 [TBL] [Abstract][Full Text] [Related]
29. Novel catanionic surfactant vesicle vaccines protect against Francisella tularensis LVS and confer significant partial protection against F. tularensis Schu S4 strain. Richard K; Mann BJ; Stocker L; Barry EM; Qin A; Cole LE; Hurley MT; Ernst RK; Michalek SM; Stein DC; Deshong P; Vogel SN Clin Vaccine Immunol; 2014 Feb; 21(2):212-26. PubMed ID: 24351755 [TBL] [Abstract][Full Text] [Related]
30. Immunoproteomics analysis of the murine antibody response to vaccination with an improved Francisella tularensis live vaccine strain (LVS). Twine SM; Petit MD; Fulton KM; House RV; Conlan JW PLoS One; 2010 Apr; 5(4):e10000. PubMed ID: 20368994 [TBL] [Abstract][Full Text] [Related]
31. Susceptibility of various mouse strains to systemically- or aerosol-initiated tularemia by virulent type A Francisella tularensis before and after immunization with the attenuated live vaccine strain of the pathogen. Shen H; Chen W; Conlan JW Vaccine; 2004 Jun; 22(17-18):2116-21. PubMed ID: 15149767 [TBL] [Abstract][Full Text] [Related]
32. An improved vaccine for prevention of respiratory tularemia caused by Francisella tularensis SchuS4 strain. Bakshi CS; Malik M; Mahawar M; Kirimanjeswara GS; Hazlett KR; Palmer LE; Furie MB; Singh R; Melendez JA; Sellati TJ; Metzger DW Vaccine; 2008 Sep; 26(41):5276-88. PubMed ID: 18692537 [TBL] [Abstract][Full Text] [Related]
33. Vaccination with a defined Francisella tularensis subsp. novicida pathogenicity island mutant (DeltaiglB) induces protective immunity against homotypic and heterotypic challenge. Cong Y; Yu JJ; Guentzel MN; Berton MT; Seshu J; Klose KE; Arulanandam BP Vaccine; 2009 Sep; 27(41):5554-61. PubMed ID: 19651173 [TBL] [Abstract][Full Text] [Related]
34. Efficacy of the live attenuated Francisella tularensis vaccine (LVS) in a murine model of disease. Green M; Choules G; Rogers D; Titball RW Vaccine; 2005 Apr; 23(20):2680-6. PubMed ID: 15780452 [TBL] [Abstract][Full Text] [Related]
35. Characterization of rationally attenuated Francisella tularensis vaccine strains that harbor deletions in the guaA and guaB genes. Santiago AE; Cole LE; Franco A; Vogel SN; Levine MM; Barry EM Vaccine; 2009 Apr; 27(18):2426-36. PubMed ID: 19368784 [TBL] [Abstract][Full Text] [Related]
36. Monophosphoryl Lipid A Enhances Efficacy of a Francisella tularensis LVS-Catanionic Nanoparticle Subunit Vaccine against F. tularensis Schu S4 Challenge by Augmenting both Humoral and Cellular Immunity. Richard K; Mann BJ; Qin A; Barry EM; Ernst RK; Vogel SN Clin Vaccine Immunol; 2017 Mar; 24(3):. PubMed ID: 28077440 [No Abstract] [Full Text] [Related]